The use of iPads and other tablet devices is on the rise in the pharmaceutical industry. Nevertheless, the level of satisfaction for digital is plummeting and Return On Investment (ROI) is still questionable. So, what’s wrong? One answer lies in the lack of proper eDetailing, or using analytic-based, interactive media to enable sales presentations to physicians.
Here are five ways eDetailing with tablets can help you drive better pharmaceutical sales:
Physicians vary widely in expertise and specialty, so why would the same message work for everyone? Addressing individual physician’s concerns on a certain topic or product with medical education tailored specifically toward the local regulatory patient compliance standards helps turn stale brochure content into a pinpointed, informative sales experience.
Using a CRM to select what detail content to use with each targeted physician takes the guesswork out of the sales representatives’ hands. Relying on this type of data intelligence ensures vital information on the individual physician will create customized interactive content more likely to engage and influence them.
The pharmaceutical industry is transforming from physician-owned practices to centralized institutions, such as Integrated Delivery Networks (IDNs) and Group Practices (GPs). The pharma sales rep can now use data to identify the most influential GPs/IDNs, as well as their network of GPs/IDNs, to focus sales efforts only on physicians in influential groups and reallocate their remaining efforts elsewhere.
Historically the pharma world has used the abundant data it collects on doctor prescribing, patient claims, outlet sales, pharma sales rep calls, marketing promotional spending, etc. to address business problems centered around brand performance and resourcing. This is company-focused though, and does little for the patient. It is better to focus on which messages are gaining traction, how long patients stay on therapy, and other customer-centric predictive analytics to drive more sustainable revenue results.
The pharmaceutical industry’s regulatory-heaving environment often creates a delay in responding to physicians’ and patients’ complex needs. Based on physicians’ prescription patterns, profile, market condition, and an array of statistical techniques, it’s possible to create an intelligent system to help you identify physicians who warrant attention (like those that have a better growth opportunity or are at risk of switching to a competitor’s product). Pharma sales reps can then modify their strategy appropriately based on these triggers/alerts to take the correct action in near real-time.
Want more? Click here to download our infographic entitled ‘Using Tablets In Detailing: Where Pharma Is Wrong’ for more information.
To help communities across the U.S. increase vaccination rates in the fight against COVID-19, SPI has recently launched a...Explore More
SPI led the US in corporate responses to defining safety standards and protocols for field operations during the COVID-19 pandemic....Explore More
In an upcoming white paper to be published this month by SPI, Fred Kessler (President and CSO Sales Partnerships, Inc.)...Explore More
Sales Partnerships, Inc. is North America’s leading field sales organization and under ‘normal’ circumstances has hundreds of sales representatives actively...Explore More
Dear SPI Community: I feel it is time for SPI to speak out about what has been happening across the...Explore More